About Beijing Rubber Xin Biological Technology
Beijing Rubber Xin Biological Technology is a company based in Haidian (China) founded in 2017.. Beijing Rubber Xin Biological Technology has raised $28.7 million across 2 funding rounds from investors including Yikai Venture Capital, Lichen Investment and Qingdao Hongteng. Beijing Rubber Xin Biological Technology operates in a competitive market with competitors including InDex Pharmaceuticals, Genedrive, SensID, Genturadx and Qantgene, among others.
- Headquarter Haidian, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$28.7 M (USD)
in 2 rounds
-
Latest Funding Round
$28.7 M (USD), Series B
Dec 27, 2022
-
Investors
Yikai Venture Capital
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Beijing Rubber Xin Biological Technology
Beijing Rubber Xin Biological Technology has successfully raised a total of $28.7M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $28.7 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $28.7M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2022 | Amount | Series B - Beijing Rubber Xin Biological Technology | Valuation | Yikai Venture Capital | |
| Apr, 2020 | Amount | Series A - Beijing Rubber Xin Biological Technology | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Beijing Rubber Xin Biological Technology
Beijing Rubber Xin Biological Technology has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Yikai Venture Capital, Lichen Investment and Qingdao Hongteng. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Beijing Rubber Xin Biological Technology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Beijing Rubber Xin Biological Technology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Beijing Rubber Xin Biological Technology Comparisons
Competitors of Beijing Rubber Xin Biological Technology
Beijing Rubber Xin Biological Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as InDex Pharmaceuticals, Genedrive, SensID, Genturadx and Qantgene, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
DNA-based immunomodulatory drugs for ulcerative colitis are developed.
|
|
| domain | founded_year | HQ Location |
Provider of point of care molecular diagnostics platform for genotyping and sequence analysis
|
|
| domain | founded_year | HQ Location |
Reference materials for DNA diagnostic applications are developed.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic platforms for clinical PCR analysis are developed.
|
|
| domain | founded_year | HQ Location |
Cancer screening blood tests are offered for early disease detection.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Beijing Rubber Xin Biological Technology
Frequently Asked Questions about Beijing Rubber Xin Biological Technology
When was Beijing Rubber Xin Biological Technology founded?
Beijing Rubber Xin Biological Technology was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is Beijing Rubber Xin Biological Technology located?
Beijing Rubber Xin Biological Technology is headquartered in Haidian, China. It is registered at Haidian, Beijing, China.
Who is the current CEO of Beijing Rubber Xin Biological Technology?
Cao Shanbai is the current CEO of Beijing Rubber Xin Biological Technology.
Is Beijing Rubber Xin Biological Technology a funded company?
Beijing Rubber Xin Biological Technology is a funded company, having raised a total of $28.7M across 2 funding rounds to date.
What does Beijing Rubber Xin Biological Technology do?
The company was founded in 2017 and is based in Haidian, China, within the biotechnology sector. Focus is placed on developing reagents and instruments for tumor genetic testing, including AcornSTAS for solid tumor mutations and AcornHMAS for hematological tumor mutations. A solid tumor gene knowledge database, AcornSTDB, is also maintained. Operations center on providing tools for genetic analysis in oncology diagnostics.
Who are the top competitors of Beijing Rubber Xin Biological Technology?
Beijing Rubber Xin Biological Technology's top competitors include C3J Therapeutics, InDex Pharmaceuticals and Bigtec Labs.
Who are Beijing Rubber Xin Biological Technology's investors?
Beijing Rubber Xin Biological Technology has 6 investors. Key investors include Yikai Venture Capital, Lichen Investment, Qingdao Hongteng, Pragmatic Capital, and Indaco Capital.